NEW YORK (GenomeWeb News) – Pharmacogenetic testing firm PGXL Laboratories announced on Thursday a long-term national distribution deal with Essential Molecular Testing for PGXL's drug sensitivity testing.

The partnership, called PGXL Partners, provides the Louisville, Ky.-based laboratory a larger sales force to address growing demand for its tests. In a statement, PGXL Labs President Roland Valdes Jr., said that the company has increased sales of its tests to thousands each month from hundreds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.